Full View

PD-L1 (CD274) promoter methylation predicts survival in colorectal cancer patients

D Goltz, H Gevensleben, J Dietrich, D Dietrich - Oncoimmunology, 2017 - Taylor & Francis
This study evaluates promoter methylation of the programmed cell death ligand 1 (PD-L1) as
a biomarker in a cohort of 383 colorectal cancer patients. PD-L1 methylation (m PD-L1) was …
被引用次数：79 相关文章

[引用][C] PD-L1 (CD274) promoter methylation predicts survival in colorectal cancer patients

D Goltz, H Gevensleben, J Dietrich, D Dietrich - OncoImmunology, 2016 - cir.nii.ac.jp
<i>PD-L1</i> (<i>CD274</i>) promoter methylation predicts survival in colorectal cancer
patients | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索 …
[HTML] nih.gov

[HTML][HTML] PD-L1 (CD274) promoter methylation predicts survival in colorectal cancer patients

D Goltz, H Gevensleben, J Dietrich, D Dietrich - Oncoimmunology, 2017 - ncbi.nlm.nih.gov
This study evaluates promoter methylation of the programmed cell death ligand 1 (PD-L1) as
a biomarker in a cohort of 383 colorectal cancer patients. PD-L1 methylation (mPD-L1) was …

PD-L1 (CD274) promoter methylation predicts survival in colorectal cancer patients.

D Goltz, H Gevensleben, J Dietrich, D Dietrich - Oncoimmunology, 2016 - europepmc.org
This study evaluates promoter methylation of the programmed cell death ligand 1 (PD-L1) as
a biomarker in a cohort of 383 colorectal cancer patients. PD-L1 methylation (mPD-L1) was …

PD-L1 (CD274) promoter methylation predicts survival in colorectal cancer patients

D Goltz, H Gevensleben, J Dietrich… - …, 2016 - pubmed.ncbi.nlm.nih.gov
This study evaluates promoter methylation of the programmed cell death ligand 1 (PD-L1) as
a biomarker in a cohort of 383 colorectal cancer patients. PD-L1 methylation (mPD-L1) was …

PD-L1 (CD274) promoter methylation predicts survival in colorectal cancer patients.

D Goltz, H Gevensleben, J Dietrich, D Dietrich - Oncoimmunology, 2016 - europepmc.org
This study evaluates promoter methylation of the programmed cell death ligand 1 (PD-L1) as
a biomarker in a cohort of 383 colorectal cancer patients. PD-L1 methylation (mPD-L1) was …